| Literature DB >> 28651908 |
Jing Dai1, Xiangdong Du2, Guangzhong Yin2, Yingyang Zhang2, Haishen Xia3, Xiaosi Li3, Rylan Cassidy4, Qingchun Tong4, Dachun Chen5, Antonio Lucio Teixeira6, Yingjun Zheng7, Yuping Ning7, Jair C Soares6, Man-Xi He8, Xiang Yang Zhang9.
Abstract
Depressive symptoms are common in first episode schizophrenia. However, the prevalence and its associations of comorbid depressive symptoms with clinical variables are less well characterized in Chinese Han patients with schizophrenia. In this cross-sectional study, we recruited 240 first-episode and drug naïve (FEDN) inpatients with schizophrenia. All patients were rated on the 17-item Hamilton Depression Rating Scale (HAMD-17) to measure depressive symptoms, and also on the Positive and Negative Syndrome Scale (PANSS) for psychopathology. Our results showed that 131 patients had a total score of 8 or more points on HAMD-17, making the prevalence of comorbid depressive symptoms 54.6%. Fewer women (48.1%, 62 of 129) than men (62.2%, 69 of 111) had comorbid depressive symptoms. Compared to those patients without depressive symptoms, those with depressive symptoms showed higher PANSS total, general psychopathology, cognitive factor and negative symptom scores (all p<0.05). Further stepwise multiple logistic regression analysis indicated that the PANSS general psychopathology, the PANSS total score and gender (all p<0.05) remained significantly associated with depressive symptoms. In addition, correlation analysis showed significant correlations between HAMD total score and the following parameters: the PANSS general psychopathology, total score, and cognitive factor (Bonferroni corrected p's<0.05). Our results suggest that depressive symptoms occur with high prevalence in FEND schizophrenia in a Chinese Han population, and show association with general psychopathology, as well as with cognitive impairment.Entities:
Keywords: Association; Depression; Prevalence; Psychopathology; Schizophrenia
Mesh:
Year: 2017 PMID: 28651908 DOI: 10.1016/j.schres.2017.06.029
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939